GlassScriptPhysician profile
Wallace Cory Williamson
NPI 1881272540
$13,221.84
in general payments reported to CMS, 2019-2025
25 companies · $2,058 in 2025
The $2,058 reported for 2025 was more than what 84% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,614 · 2022: $2,858 · 2023: $1,607 · 2024: $4,084 · 2025: $2,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,848 · Travel and Lodging: $1,902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,847.72 |
| Travel and Lodging | $1,901.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reel Surgical, INC. | $4,986.10 | 2021-2024 | |
| Stryker Corporation | $3,781.33 | 2022-2024 | Ortholoc 3di, Citrefix, Prostep |
| Arthrex, INC. | $1,029.53 | 2024-2025 | |
| Integra Lifesciences Corporation | $617.98 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $557.92 | 2022-2025 | Renasys Go V2 Home, Pico 14, Stravix |
| Sanara Medtech INC. | $367.31 | 2024-2025 | Celleraterx, Celleraterx |
| Treace Medical Concepts, INC. | $325.33 | 2022-2025 | |
| Linvatec Corporation | $264.37 | 2023-2024 | Allograft Tissue, Colink Neofuse |
| Ebi, LLC | $227.81 | 2025 | Ebi Osteogen Implantable Bone Growth Stimulator |
| Highridge Medical LLC | $196.56 | 2025 | Ebi Osteogen Implantable Bone Growth Stimulator |
| Bone Support INC. | $138.38 | 2024 | Ceramentbone Void Filler, Cerament G |
| Aroa Biosurgery Incorporated | $120.23 | 2024 | |
| Flower Orthopedics Coporation | $114.47 | 2025 | |
| Fusion Orthopedics USA, LLC | $107.92 | 2025 | |
| Paratek Pharmaceuticals, INC. | $92.25 | 2025 | Nuzyra |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $66.62 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Zimvie INC. | $62.12 | 2023-2024 | |
| International Life Sciences | $47.31 | 2024 | Flexband |
| Solventum Corporation | $23.46 | 2025 | Activ.A.C. |
| Globus Medical, INC. | $21.21 | 2025 | Senza |
| Kerecis Limited | $18.78 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Amgen INC. | $16.24 | 2025 | Krystexxa |
| Cashflow Solutions, LLC | $14.47 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Paragon 28, INC. | $14.42 | 2025 | Phantom Fibula Nail |
| Orthofix Medical, INC. | $9.72 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wallace Williamson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.